Replimune Group investors sue over alleged securities fraud.

A class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) alleging securities fraud between November 22, 2024 and July 21, 2025. The lawsuit seeks to recover losses on behalf of investors who were adversely affected by the alleged misconduct. Investors may contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500 to learn more and be contacted by a member of the team.

A class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL), alleging securities fraud between November 22, 2024 and July 21, 2025. The lawsuit seeks to recover losses on behalf of investors who were adversely affected by the alleged misconduct.

The complaint alleges that during the class period, Replimune Group, Inc. made materially false and misleading statements and/or failed to disclose that: (1) the company recklessly overstated the prospects of the IGNYTE trial, despite material issues that the company knew or should have known, leading to the FDA deeming the trial inadequate and not well-controlled; and (2) as a result, the company's statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times [1].

Investors who purchased or acquired Replimune Group, Inc. securities during the specified period are encouraged to contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500 to learn more and be contacted by a member of the team [4].

The deadline to request that the Court appoint a lead plaintiff is September 22, 2025. Investors who suffer a loss in Replimune Group, Inc. during the relevant time frame may be entitled to compensation without payment of any out-of-pocket costs or fees [4].

References:
[1] https://www.globenewswire.com/news-release/2025/08/18/3134966/0/en/SHAREHOLDER-ALERT-Bernstein-Liebhard-LLP-Announces-A-Securities-Fraud-Class-Action-Lawsuit-Has-Been-Filed-Against-Replimune-Group-Inc-NASDAQ-REPL.html
[2] https://www.morningstar.com/news/globe-newswire/9516385/class-action-filed-against-replimune-group-inc-repl-seeking-recovery-for-investors-contact-the-gross-law-firm
[3] https://www.globenewswire.com/news-release/2025/08/21/3137517/9788/en/REPL-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-Replimune-Group-Inc-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit.html
[4] https://www.prnewswire.com/news-releases/shareholders-that-lost-money-on-replimune-group-increpl-should-contact-levi--korsinsky-about-pending-class-action---repl-302536168.html